Pheast Therapeutics
Sarah Fernandes is an accomplished professional in project management and pharmacology, currently serving as the Director of Project Management at Pheast Therapeutics since November 2023. Previously, Sarah held the position of Director of Project Management at Circle Pharma, Inc. and served as an Early Development Project Manager at Bristol Myers Squibb, where support focused on neurosciences and cardiovascular projects. With extensive experience at MyoKardia as a Senior Project Manager and Senior Research Scientist in Pharmacology, Sarah demonstrated adeptness in managing development programs and leading scientific initiatives. Earlier roles include Research Scientist at Gilead Sciences, specializing in preclinical studies. Sarah holds a PhD in Cell Biology from Nantes Université and a Master's degree in Experimental Pharmacology from Paris-Sud University.
This person is not in any teams
This person is not in any offices
Pheast Therapeutics
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.